What's Happening?
A new clinical trial, co-led by researchers from the University of Manchester, has been initiated to explore the effectiveness of cognitive analytic therapy (CAT) for young individuals aged 13-17 who struggle with self-harm. This trial, named RELATE-YP,
is funded by the National Institute for Health and Care Research (NIHR) and is sponsored by the Pennine Care NHS Foundation Trust. The trial aims to address the increasing prevalence of self-harm among young people in the UK, which poses significant concerns for the individuals, their families, and supporting services. The trial is a feasibility study to determine if CAT, which focuses on the relationships young people have with themselves and others, can be a suitable treatment for self-harm. The study is being conducted across three NHS Foundation Trusts and is recruiting participants through Child and Adolescent Mental Health Services (CAMHS).
Why It's Important?
The trial is significant as it addresses a growing mental health issue among young people. Self-harm is associated with various psychological difficulties and can have long-term impacts if not addressed effectively. By exploring CAT, which differs from other therapies by focusing on relational patterns, the trial could potentially offer a new, effective treatment option for young people. This could lead to better mental health outcomes and reduce the burden on healthcare services. The involvement of young people with personal experiences of self-harm in the trial design ensures that the therapy is tailored to meet the needs of those it aims to help.
What's Next?
The RELATE-YP trial will assess the feasibility of CAT as a treatment for self-harm in young people. If successful, it could pave the way for a larger trial to further evaluate the therapy's effectiveness. The trial's outcomes could influence future mental health treatment protocols and policies, potentially leading to wider adoption of CAT in clinical settings. Stakeholders, including healthcare providers and policymakers, will be closely monitoring the trial's progress and results to determine the next steps in addressing self-harm among youths.
